These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15617726

  • 1. Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels.
    Zapata A, Shippenberg TS.
    Neuropharmacology; 2005 Jan; 48(1):43-50. PubMed ID: 15617726
    [Abstract] [Full Text] [Related]

  • 2. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
    Pugsley TA, Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgic LM, Cooke LW.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses.
    Zapata A, Witkin JM, Shippenberg TS.
    Neuropharmacology; 2001 Sep; 41(3):351-9. PubMed ID: 11522326
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A, Kulkarni SK.
    Brain Res Bull; 2007 Sep 14; 74(1-3):58-65. PubMed ID: 17683790
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
    Ryoo HL, Pierrotti D, Joyce JN.
    Mov Disord; 1998 Sep 14; 13(5):788-97. PubMed ID: 9756147
    [Abstract] [Full Text] [Related]

  • 8. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors.
    Robertson GS, Lee CJ, Sridhar K, Nakabeppu Y, Cheng M, Wang YM, Caron MG.
    Eur J Neurosci; 2004 Dec 14; 20(11):3189-94. PubMed ID: 15579174
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
    Le Foll B, Diaz J, Sokoloff P.
    Life Sci; 2005 Jan 28; 76(11):1281-96. PubMed ID: 15642598
    [Abstract] [Full Text] [Related]

  • 13. D(3) receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens.
    Zapata A, Shippenberg TS.
    J Neurochem; 2002 Jun 28; 81(5):1035-42. PubMed ID: 12065616
    [Abstract] [Full Text] [Related]

  • 14. Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging.
    Ireland MD, Lowe AS, Reavill C, James MF, Leslie RA, Williams SC.
    Neuroscience; 2005 Jun 28; 133(1):315-26. PubMed ID: 15893653
    [Abstract] [Full Text] [Related]

  • 15. Effect of methamphetamine on cognition and repetitive motor behavior of mice deficient for dopamine D2 and D3 receptors.
    Glickstein SB, Schmauss C.
    Ann N Y Acad Sci; 2004 Oct 28; 1025():110-8. PubMed ID: 15542707
    [Abstract] [Full Text] [Related]

  • 16. Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice.
    Pappas SS, Behrouz B, Janis KL, Goudreau JL, Lookingland KJ.
    Brain Res; 2008 Jun 12; 1214():1-10. PubMed ID: 18462709
    [Abstract] [Full Text] [Related]

  • 17. Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907].
    Witkin JM, Dijkstra D, Levant B, Akunne HC, Zapata A, Peters S, Shannon HE, Gasior M.
    J Pharmacol Exp Ther; 2004 Mar 12; 308(3):957-64. PubMed ID: 14711932
    [Abstract] [Full Text] [Related]

  • 18. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.
    Koeltzow TE, Xu M, Cooper DC, Hu XT, Tonegawa S, Wolf ME, White FJ.
    J Neurosci; 1998 Mar 15; 18(6):2231-8. PubMed ID: 9482807
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists.
    Boulay D, Depoortere R, Perrault G, Borrelli E, Sanger DJ.
    Neuropharmacology; 1999 Sep 15; 38(9):1389-96. PubMed ID: 10471093
    [Abstract] [Full Text] [Related]

  • 20. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice.
    Chausmer AL, Elmer GI, Rubinstein M, Low MJ, Grandy DK, Katz JL.
    Psychopharmacology (Berl); 2002 Aug 15; 163(1):54-61. PubMed ID: 12185400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.